Risk Factors for All-Cause and Cause-Specific Mortality in Patients with Chronic Kidney Disease: Age-Specific Associations and Attributable Burden [0.03%]
慢性肾脏病患者全因及病因特异性死亡的风险因素:年龄特异性的关联和可归因负担
Jie Mei,Yuk Kam Yau,Franco Wing Tak Cheng et al.
Jie Mei et al.
Introduction: Evidence regarding age-specific associations between risk factors and mortality in patients with chronic kidney disease (CKD) remains limited. We sought to investigate these age-specific associations and to ...
Enoxolone Alleviates Renal Fibrosis in Diabetic Kidney Disease by Inhibiting the Smad3-Smad4 Complex [0.03%]
恩可索通过抑制Smad3-Smad4复合体治疗糖尿病肾病诱导的肾纤维化
Beiduo Lv,Zhaochen Guo,Zige Chen et al.
Beiduo Lv et al.
Introduction: This study aimed to explore the ameliorative effects of enoxolone on renal fibrosis in diabetic kidney disease (DKD) and elucidate its underlying molecular mechanisms, thereby proposing a novel candidate dru...
Relationship of Renal Replacement Therapy to Cancer Site: A Hospital-Based Analysis in Osaka, Japan [0.03%]
日本大阪基于医院的分析:肾脏替代治疗与癌症部位的关系
Eiji Uza,Hirota Kida,Michioki Kuri
Eiji Uza
Introduction: Cancer patients are at risk for acute kidney injury (AKI) due to anticancer agents, tumor lysis syndrome, sepsis, and contrast-induced nephropathy. Renal replacement therapy (RRT) is associated with longer h...
Urinary Glucose Concentration as a Predictor of Proteinuria Reduction in Chronic Kidney Disease Patients Treated with Sodium-Glucose Cotransporter 2 Inhibitors [0.03%]
钠-葡萄糖共转运体2抑制剂治疗慢性肾脏病患者尿蛋白减少的预测因素:一项回顾性研究
Xueqi Wang,Jie Wang,Shuwen Zhou et al.
Xueqi Wang et al.
Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are crucial in managing proteinuria in chronic kidney disease (CKD), yet individual responses vary. Whether urinary glucose excretion, a direct pharmacodyn...
Safety and Efficacy of the First Mobile Intelligent Hemodialysis Platform in Mainland China: Protocol for a Single-Center Prospective Exploratory Study in Maintenance Hemodialysis Patients [0.03%]
中国首次移动智能血液透析平台在维持性血液透析患者中的安全性与有效性:单一医疗中心前瞻性研究方案
Renhua Lu,Yan Fang,Qisheng Lin et al.
Renhua Lu et al.
Introduction: End-stage kidney disease (ESKD) is a growing global public health burden, with millions of patients dependent on maintenance hemodialysis (MHD). Conventional center-based MHD imposes significant constraints ...
Elevated Serum LL37 and Myeloperoxidase-DNA Complexes Predict the Progression of Diabetic Kidney Disease [0.03%]
血清LL37和髓过氧化物酶-DNA复合物可预测糖尿病肾脏疾病的进展
Pingping Ren,Huiling Cao,Xiaoli Wen et al.
Pingping Ren et al.
Background: Predicting early progression of diabetic kidney disease (DKD) remains challenging. The neutrophil-derived peptide LL37 is implicated in kidney inflammation, yet its role and prognostic value in DKD remain uncl...
Exploring the Role of Microbiota-Mediated Gut-Kidney Axis in Acute Kidney Injury: Immunomodulation and Therapy [0.03%]
探究肠道菌群介导的肠-肾轴在急性肾脏损伤中的作用:免疫调节和治疗
Litong Zhu,Shifeng Jiang,Qiulong Yan et al.
Litong Zhu et al.
Background: Acute kidney injury (AKI) remains a major clinical problem characterized by high morbidity and an increased risk of progression to chronic kidney disease (CKD). Immune cell infiltration and activation are impo...
Peripheral Blood Lymphocyte Subsets and Clinical Parameters in Patients Undergoing Renal Biopsy [0.03%]
肾活检患者的外周血淋巴细胞亚群及临床参数分析
Xingyang Zhao,Meng Wang,Sujia Hu et al.
Xingyang Zhao et al.
Introduction: Chronic kidney disease (CKD) is a major global health burden characterized by immune dysregulation. Peripheral blood lymphocyte subsets can reflect immune status across CKD pathologies. We evaluated associat...
Efficacy and Cardiovascular Safety of Pegmolesatide in Patients with Anemia of Chronic Kidney Disease: Post hoc Analysis of Two Phase 3 Randomized Trials [0.03%]
PEGMOLESATIDE治疗慢性肾脏病贫血患者的有效性和心血管安全性:两项随机三期临床试验的事后分析
Zhiming Ye,Ping Zhang,Zhizhen Hu et al.
Zhiming Ye et al.
Introduction: Pegmolesatide selectively binds to the erythropoietin receptor homodimer with higher binding stability and prolonged residency than erythropoietin, potentially offering an improved therapeutic profile for an...
Therapeutic Applications of Induced Pluripotent Stem Cell Technology in Kidney Disease: A Systematic Review and Meta-Analysis [0.03%]
诱导多能干细胞技术在肾脏疾病治疗中的应用:系统性回顾和荟萃分析
Lan Anh Thi Ke,Anh Ngoc Nguyen,Nguyet Minh Pham et al.
Lan Anh Thi Ke et al.
Introduction: Kidney disease is a major global health burden with limited regenerative treatment options. Induced pluripotent stem cells (iPSCs) offer patient-specific pluripotency and the potential to generate renal cell...